Epidermal growth factor receptor inhibition for the treatment of glioblastoma multiforme and other malignant brain tumours.
about
Identification of noninvasive imaging surrogates for brain tumor gene-expression modulesPI3K/Akt/mTOR signaling pathway and targeted therapy for glioblastomaSpecific visualization of glioma cells in living low-grade tumor tissueEGFR inhibition in glioma cells modulates Rho signaling to inhibit cell motility and invasion and cooperates with temozolomide to reduce cell growthEnhanced Therapeutic Epidermal Growth Factor Receptor (EGFR) Antibody Delivery via Pulsed Ultrasound with Targeting Microbubbles for Glioma TreatmentPotential role of preoperative conventional MRI including diffusion measurements in assessing epidermal growth factor receptor gene amplification status in patients with glioblastomaThe interference of Notch1 target Hes1 affects cell growth, differentiation and invasiveness of glioblastoma stem cells through modulation of multiple oncogenic targetsFunctional delivery of siRNA in mice using dendriworms.Overexpression of c-erbB2 is a negative prognostic factor in anaplastic astrocytomas.Role of receptor tyrosine kinases and their ligands in glioblastoma.GRIM-19 Expression and Function in Human Gliomas.Glioblastoma biomarkers from bench to bedside: advances and challenges.A prognostic analysis of pediatrics central nervous system small cell tumors: evaluation of EGFR family gene amplification and overexpression.PDGF receptor alpha inhibition induces apoptosis in glioblastoma cancer stem cells refractory to anti-Notch and anti-EGFR treatment.Targeting class IA PI3K isoforms selectively impairs cell growth, survival, and migration in glioblastoma.Innovative Therapies against Human Glioblastoma MultiformeNanostructured Pt(NH(3))(4)Cl(2)/SiO(2) for nanomedicine: catalytic degradation of DNA in cancer cellsTherapeutic anti-EGFR antibody 806 generates responses in murine de novo EGFR mutant-dependent lung carcinomas.Concurrent hypermethylation of DNMT1, MGMT and EGFR genes in progression of gliomas.Translational up-regulation of the EGFR by tumor hypoxia provides a nonmutational explanation for its overexpression in human cancer.Activation of multiple ERBB family receptors mediates glioblastoma cancer stem-like cell resistance to EGFR-targeted inhibition.Complex oncogenic signaling networks regulate brain tumor-initiating cells and their progenies: pivotal roles of wild-type EGFR, EGFRvIII mutant and hedgehog cascades and novel multitargeted therapies.Overexpression of TIP30 inhibits the growth and invasion of glioma cells.A phase I/II trial of vandetanib for patients with recurrent malignant glioma.A novel taspine analog, HMQ1611, inhibits growth of non-small cell lung cancer by inhibiting angiogenesis.Histone methylase MLL1 has critical roles in tumor growth and angiogenesis and its knockdown suppresses tumor growth in vivo.Enhanced brain accumulation of pazopanib by modulating P-gp and Bcrp1 mediated efflux with canertinib or erlotinib.ErbB receptors and epithelial-cadherin-catenin complex in human carcinomas.Assessing current therapeutic approaches to decode potential resistance mechanisms in glioblastomas.Emerging monoclonal antibody therapies for malignant gliomas.Inhibiting kinases in malignant gliomas.Molecularly targeted therapies for malignant gliomas: advances and challenges.PACAP and VIP Inhibit the Invasiveness of Glioblastoma Cells Exposed to Hypoxia through the Regulation of HIFs and EGFR ExpressionMolecularly targeted therapies for malignant gliomas.EGF receptor variant III as a target antigen for tumor immunotherapy.New strategies to deliver anticancer drugs to brain tumors.Therapeutic targeting of EGFR in malignant gliomas.Molecular diagnostics of gliomas: state of the art.Recent advances in brain tumor-targeted nano-drug delivery systems.Molecular markers of glioma: an update on recent progress and perspectives.
P2860
Q24647449-4F5ADB03-2359-46AC-B2E8-7CDD6CFD65D1Q26766293-8F766384-AE84-48D8-9646-B61DBEE03C89Q27324581-0646784A-6B41-423A-A25E-BE981C7CAA75Q28728770-F7CE5CF9-DF8D-4DE9-9167-13B5F24AA3DEQ30412519-71EEAD39-18E4-4921-8957-20D6D8CA06D1Q30652283-955A4727-C0E2-4760-B8F4-78B497054A0AQ33566723-D8224219-5CAB-4F5F-AA8C-EC659F8D0CB4Q33686651-6F666006-DD72-4658-8DC5-D368E802023CQ33809397-6F429C03-EB26-42FC-A2C7-E74F9517E77DQ33883849-69BD4155-5226-40F0-B9BB-C9B51A05478DQ34044498-EF31129D-130A-44A7-91D8-F3AC6D364F92Q34103890-25F93D20-0F9B-4F4A-8F75-2EF3E1C236D2Q34486255-3DC88D3F-0F88-40C2-A9DD-3043AEA42382Q34535041-4FF2582D-D754-48D6-9373-B2DAA25616DFQ35143738-3F238AE2-C253-465B-8809-1BD3C7DA4752Q35374492-E14BE80F-2EB1-441F-962E-69F8C4DEAB7BQ35547337-D8D99F35-F525-400E-A0F4-5FF1165BE892Q35589285-727E1811-FD6B-4966-8D8C-024A5890CA04Q35800058-35196283-25D9-4EFD-B37B-B50D67C0E70BQ35928801-403C9C21-1BB5-49FC-AE70-1CE8D228DB01Q36062158-91C362AC-09D2-43CB-BD0C-A345CB6E5F6EQ36280796-50F8D09D-9882-463E-9B24-537BE7A61D15Q36390275-485F85FC-F380-47D0-8DB5-4B823055E523Q36401846-F9ADF6D7-498C-46DA-B46A-6C4FCFF6145CQ36403368-4A7072FC-DB72-40B2-ACA1-4A70A52C2BE8Q36438203-620F0EDC-57ED-4DB0-A70F-643EE12494D3Q36613936-D22B749C-5570-4CB1-8AAC-16A01BBCD188Q36677496-38F9A42E-D245-4F8A-9C79-9F440487AB13Q36695514-A80547F6-F0B0-4E99-820A-37C9CDAEB4A2Q36764016-49AF39AD-2294-4C78-9463-4FA104D7D06BQ36764876-5DB52A57-52BE-4E3E-87F9-D43D3E4FF556Q36817109-4E3A028A-0C73-4C99-A205-34C9FBA81211Q36948641-4B9CEBBB-F1DB-4E71-920E-DD70455A2980Q37107374-A7F54EB4-5962-44B7-B548-83B0A164794BQ37259602-58C5DB74-8C22-4C9F-9DAC-9CC2919AB67BQ37364700-4FE03B04-0959-4F6E-97AE-53F1E03B7A75Q37690755-CF723DB5-2CF4-4CC9-B4EC-00EA09ADB4F9Q37780495-353AEC6A-8208-448E-A2F4-59955143739BQ38011262-272F2E7C-E3A5-468A-A8B2-914202D993EEQ38050966-25ED3B9B-A808-4382-8210-73B6B9C03E5D
P2860
Epidermal growth factor receptor inhibition for the treatment of glioblastoma multiforme and other malignant brain tumours.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年学术文章
@wuu
2006年学术文章
@zh-cn
2006年学术文章
@zh-hans
2006年学术文章
@zh-my
2006年学术文章
@zh-sg
2006年學術文章
@yue
2006年學術文章
@zh
2006年學術文章
@zh-hant
name
Epidermal growth factor recept ...... other malignant brain tumours.
@ast
Epidermal growth factor recept ...... other malignant brain tumours.
@en
type
label
Epidermal growth factor recept ...... other malignant brain tumours.
@ast
Epidermal growth factor recept ...... other malignant brain tumours.
@en
prefLabel
Epidermal growth factor recept ...... other malignant brain tumours.
@ast
Epidermal growth factor recept ...... other malignant brain tumours.
@en
P2093
P1476
Epidermal growth factor recept ...... other malignant brain tumours.
@en
P2093
Christian Rainer Wirtz
Julianne Behnke-Mursch
Ursula Schmidt
P356
10.1016/J.CTRV.2006.01.003
P577
2006-02-20T00:00:00Z